The company said its GRN163 is a specific
and nontoxic inhibitor of telomerase that is active against all major human tumor types in vitro and in animal models of human brain, prostate, lymphoma, myeloma and cervical cancers. Geron noted that unlike many cancer drugs, the compound hasn't caused toxicity in animals at therapeutically effective doses.
lotsa risk, sure, but all the evidence says this has a good chance of being real.
i say its the best lottery ticket out there.........
and that s just PART of what they are doing